|
|
|
|
Departamento de Fisiología, Universidad de Extremadura, Cáceres, Spain (B.R.); Departments of Infectious Diseases (S.J.) and Genetics and Tumor Cell Biology (J.M.L.), St. Jude Children's Research Hospital, Memphis, Tennessee; and Institut de Neurociències and Departament de Bioquímica i Biología Molecular, Universitat Autònoma de Barcelona, Barcelona, Spain (E.C.).
The mechanism of cell death triggered by C2-ceramide was
investigated using the NB16 neuroblastoma cell line. Treatment of NB16 cells
with 20 µM C2-ceramide for 20 h resulted in approximately 75%
loss of cell viability, but only 25% of cells were scored as apoptotic based
on terminal deoxynucleotidyl transferase nick-end labeling. Ultrastructural
analysis revealed early development of necrotic cytoplasmic vacuolization.
After 20 h of treatment with C2-ceramide, the majority of cells
possessed necrotic morphology with pronounced cytoplasmic vacuolization and
without any nuclear changes, although a quarter of the cell population also
exhibited clear perinuclear chromatin condensation characteristic of
apoptosis. Flow cytometric analysis of cells labeled with both annexin V and
propidium iodide showed the rapid accumulation of
C2-ceramidetreated cells in the necrotic/late apoptotic
fraction. In contrast, cells treated with tumor necrosis factor
plus
cycloheximide (TNF
+ CHX) first appeared in the early apoptotic
fraction and then accumulated in the necrotic/late apoptotic fraction. Both
C2-ceramide and TNF
+ CHX increased caspase 8- and 3-like
activities in cytosolic extracts; however, treatment of cells with the
broad-spectrum caspase inhibitor
N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone protected NB16
cells from TNF
+ CHX-induced cell death but did not prevent
C2-ceramide cytotoxicity. Although C2-ceramide triggered
apoptosis in a fraction of the cells, cell death in the population was
primarily caused by necrosis. Thus, C2-ceramide does not
faithfully mimic the effects of apoptotic ligands such as TNF
, which
are thought to be mediated by an accumulation of endogenous ceramide. The
inhibition of phosphatidylcholine synthesis is a target for
C2-ceramidemediated cytotoxicity, and this work suggests
that other agents that kill cells by inhibiting this pathway may also use a
mixture of mechanisms, including necrosis as well as apoptosis.
Received December 9, 2002; accepted May 13, 2003.
Address correspondence to: Dr. Suzanne Jackowski, Protein Science Division, Department of Infectious Diseases, St Jude Children's Research Hospital, 332 North Lauderdale St., Memphis, TN 38105-2794. E-mail: suzanne.jackowski{at}stjude.org
This article has been cited by other articles:
![]() |
A. Gubern, M. Barcelo-Torns, J. Casas, D. Barneda, R. Masgrau, F. Picatoste, J. Balsinde, M. A. Balboa, and E. Claro Lipid Droplet Biogenesis Induced by Stress Involves Triacylglycerol Synthesis That Depends on Group VIA Phospholipase A2 J. Biol. Chem., February 27, 2009; 284(9): 5697 - 5708. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Thon, H. Mohlig, S. Mathieu, A. Lange, E. Bulanova, S. Winoto-Morbach, S. Schutze, S. Bulfone-Paus, and D. Adam Ceramide mediates caspase-independent programmed cell death FASEB J, December 1, 2005; 19(14): 1945 - 1956. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jackowski and P. Fagone CTP:Phosphocholine Cytidylyltransferase: Paving the Way from Gene to Membrane J. Biol. Chem., January 14, 2005; 280(2): 853 - 856. [Full Text] [PDF] |
||||
![]() |
J. Zweigner, S. Jackowski, S. H. Smith, M. van der Merwe, J. R. Weber, and E. I. Tuomanen Bacterial Inhibition of Phosphatidylcholine Synthesis Triggers Apoptosis in the Brain J. Exp. Med., July 6, 2004; 200(1): 99 - 106. [Abstract] [Full Text] [PDF] |
||||